Displaying 91 - 100 of 325
    Graft vs Host Disease (GvHD)
        
          Updated: 
        
      
    
              
        Graft vs Host Disease, known as GvHD, is a side effect of a life saving procedure. People who undergo an allogeneic stem cell transplant - when a donor's stem cells are transplanted into the recipient - can experience either acute or chronic GvHD. In this podcast, listen to…
      
    
              
        Treatment and side effects
      
    
    
  Precision medicine: Finding the right treatment and improving treatments for each of us
        
          Updated: 
        
      
    
              
        Scientists continue to gain a deeper understanding of the genetic changes that lead to the development of cancers. This knowledge is being used to develop more precise treatments for blood cancers, especially in Acute Myeloid Leukemia (AML). 
 
In this webcast, Dr…
    
              In this webcast, Dr…
        Research, Treatment and side effects
      
    
    
  Causes of blood cancer - What we know - Innovation and Research Webcast Series 2023
        
          Updated: 
        
      
    
              
        In this presentation, Dr. John Dick, one of Canada’s pioneering scientists in the field of “cancer stem cells”, will explain how his research into the causes of blood cancers holds the promise for improved treatments and quality of life for Canadians affected by blood cancers.
      
    
              
        Diagnosis and tests, Leukemia, Research
      
    
    
  How your gut health can improve your blood cancer treatment and quality of life: Webcast
        
          Updated: 
        
      
    
              
        In this "Innovation in Research" webcast recording, you will learn about the community of microbes (bacteria, fungi, viruses and their genes) living within our digestive tracts, known as the “gut microbiome,” and how it can play a role in blood cancer treatment and…
      
    
              
        Research, Treatment and side effects
      
    
    
  Understanding ribonucleic acid (RNA) and its role in leukemia: 2024 Leukemia Conference
        
          Updated: 
        
      
    
              
        RNA is more than just DNA's lesser-known cousin. Dr. Katherine Borden, Professor, Pathology, Cell Biology at the Institute for Research in Immunology and Cancer, University of Montreal and Dr. Sarit Assouline, chief of the Division of Hematology at the JGH and Senior…
      
    
              
        Leukemia, Research
      
    
    
  Artificial Intelligence and the Future of Blood Cancers webcast
        
          Updated: 
        
      
    
              
        In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research…
      
    
              
        Research
      
    
    
  Understanding multiple myeloma
        
          Updated: 
        
      
    
              
        Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
      
    
              
        Myeloma
      
    
    
  Problems sleeping during and after treatment
        
          Updated: 
        
      
    
              
        Cancer treatments can disrupt sleep. Find out how treatments can affect sleep and what strategies you can use to sleep better.
      
    
              
        Treatment and side effects
      
    
    
  Immune effector cell-associated neurotoxicity syndrome (ICANS)
        
          Updated: 
        
      
    
              
        Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
      
    
              
        Treatment and side effects
      
    
    
  Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
        
          Updated: 
        
      
    
              
        Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
      
    
              
        Myeloproliferative neoplasms
      
    
    
   
   
   
  